ResearcherInstitut für Klinische Krebsforschung IKF GmbHNo recent work listed

Salah-Eddin Al-Batran

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: ClinicalTrials.gov.

Their work

Papers: 0
Trials: 1
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2020: 1 trial

Trials 1

PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) Study director NCT04484636 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Arndt Vogel · 1 shared trial, 2020 · strength 0.36
- Trial PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) NCT04484636 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.